Showing 15 posts of 79 posts found.


AstraZeneca’s Calquence fails to improve survival rates in coronavirus patients

November 12, 2020
Business Services AZ, AstraZeneca, Calquence

AstraZeneca’s Calquence has failed to improve survival rates and prevent lung failure in patients hospitalised with COVID-19.  Calquence (acalabrutinib) is …


European Commission agrees deal with Janssen for 200 million doses of its COVID-19 vaccine

October 9, 2020
Medical Communications AZ, AstraZeneca, Janssen

The European Commission has approved an agreement with Johnson & Johnson for the supply of 200 million doses of Janssen’s …


AstraZeneca’s Brilinta reduces the rate of stroke and death in patients with acute ischaemic stroke or transient ischaemic attack

July 16, 2020
Business Services AZ, AstraZeneca, drug trials

AstraZeneca’s Phase 3 THALES trial showed that Brilinta (ticagrelor) significantly reduced the rate of death or stroke in patients with …


AstraZeneca invests “tens of millions” into Cheshire, UK manufacturing site

August 29, 2017
Manufacturing and Production, Research and Development AZ, AstraZeneca, Cheshire, Chesire, UK, life sciences, pharma, pharmaceuticals

AstraZeneca has announced plans to invest a multi-million sum into its £150 million facility in Macclesfield, Chesire, UK – a …


GSK’s new President of Global Pharma join date revealed as AZ drops lawsuit

June 20, 2017
Business Services, Manufacturing and Production AZ, AstraZeneca, GSK, GlaxoSmithKline, Luke Miels

The transition of former AstraZeneca Executive Vice President for Europe Luke Miels to rival pharma giant GlaxoSmithKline has not been …


AZ launches lawsuit against former executive for defecting to GSK

May 17, 2017
Manufacturing and Production, Research and Development AZ, AstraZeneca, GSK, GlaxoSmithKline

AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …


Major pharma firms join Liverpool Uni in £14m pharmacovigilance project

January 30, 2017
Research and Development, Sales and Marketing AZ, AbbVie, Eli Lilly, GSK, University of Liverpool, pharmacovigilance

The UK’s University of Liverpool is to launch a £14 million pharmacovigilance project focused on using new modelling approaches to …


AZ and Lilly come together to battle Alzheimer’s

December 9, 2016
Research and Development, Sales and Marketing AZ, lilly

Pharma titans Eli Lilly and AstraZeneca have announced they are to join forces to co-develop a potential Alzheimer’s treatment, currently …


AZ reveals compelling PhIII data for ovarian cancer treatment

October 26, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AstraZeneca, lynparza

AstraZeneca has revealed new results from a Phase III trial investigating the efficacy of its Lynparza drug as a monotherapy …


AZ “disappointment” at heart drug failure

October 5, 2016
Research and Development AZ, AstraZeneca, trial failure

AstraZeneca has expressed its disappointment that its heart drug Brilinta (ticagrelor) failed to meet its primary endpoint in a recent …

Pfizer breast cancer drug delivers

June 1, 2015
Sales and Marketing ASCO, AZ, Faslodex, Pfizer, breast cancer, brett wells

A Phase III study on Pfizer’s treatment Ibrance in combination with hormone therapy has revealed the drug more than doubled …

Analysts predict Pfizer to swallow GSK

May 21, 2015
Sales and Marketing AZ, GSK, GlaxoSmithKline, Pfizer, merger

GlaxoSmithKline has been suggested as a potential M&A target for Pfizer, despite the US company backing out of a similar …

Astrazeneca image

AstraZeneca eyes success in immuno-oncology combinations

May 14, 2015
Sales and Marketing ASCO, AZ, AstraZeneca, CTLA-4, MEDI4736

An investigational immuno-oncology drug combination from AstraZeneca has shown promise in its most recent trial, although concerns over its side …

ASCO image

Pharma reveals its ASCO presentation data

May 12, 2015
Research and Development, Sales and Marketing ASCO, AZ, AbbVie, Roche, chicago, data

AstraZeneca, Genentech and AbbVie have all revealed which cancer drugs they will show data for at The American Society of …

astrazeneca image

AstraZeneca lung drug shows promise

April 20, 2015
Sales and Marketing AZ, AZD9291, AstraZeneca, European Lung Cancer Congress, NSCLC, Orphan

AstraZeneca’s non-small cell lung cancer offering AZD9291 has been shown to delay disease progression by over a year. Data presented …

Latest content